In addition to increasingly severe physical symptoms, Parkinson's can cause distressing mental health issues. These include anxiety, depression, and memory and thinking problems, caused by a combination of biological and psychological factors. They can be more disabling than physical symptoms, reduce quality of life and increase risk of mortality. They are also upsetting for family members and unpaid carers, and may necessitate transfer to institutional care. They also increase NHS costs because of expensive hospital admissions. Despite this, there are few specialist mental health professionals or psychological interventions available to help people with Parkinson's. This study will address this by developing an effective programme of evidence-based psychological interventions for mental health issues in Parkinson's that can be easily delivered by non-experts. Parkinson's mental health specialists at UCL Queen Square Institute of Neurology will work with people affected by Parkinson's and non-psychology health professionals to design specialist interventions for three key mental health needs in Parkinson's, targeted at distinct stages: 1. Adjusting to diagnosis; empowering people to feel more in control. 2. Anxiety and/or depression; using cognitive-behavioural therapy techniques to improve mood, with particular focus on Parkinson's-specific concerns. 3. Advanced Parkinson's; helping people with Parkinson's and those around them to improve management of memory and thinking problems. The research team will design companion booklets for participants, summarizing each session. The treatment will be piloted for one year. If the interventions prove beneficial to participants and are cost-effective, the resources will be made immediately available to healthcare staff across the UK to improve access to specialist psychological services.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
180
Group-based psychological therapy for (1) adjusting to diagnosis; (2) Parkinson's anxiety and/or depression; and (3) Parkinson's-related cognitive decline
University College London
London, United Kingdom
GAD-7
Standardized measure of anxiety
Time frame: Change in GAD-7 scores after 8 weeks of intervention
PHQ-9
Standardized measure of depression
Time frame: Change in PHQ-9 scores after 8 weeks of intervention
PDQ-39
Standardized measure of quality of life in Parkinson's disease
Time frame: Change in PDQ-39 scores after 8 weeks of intervention
Brief-COPE
Standardized measure of coping
Time frame: Change in Brief-COPE scores after 8 weeks of intervention
Healthcare resource use
Use of healthcare resources as measured by Client Service Receipt Inventory (CSRI)
Time frame: Change in CSRI healthcare use after 8 weeks of intervention
Acceptability
Quantitative indicator of acceptability, as measured by Likert scales on questionnaire
Time frame: Following the 8 week intervention
Acceptability
Qualitative indicator of acceptability from thematic analysis of open-ended questions on questionnaires and focus group interviews
Time frame: Following the 8 weeks of intervention
Ease of delivery by non-experts
Ease of delivery by non-experts, determined by comparing change in GAD-7 by intervention lead (nurse vs psychologist)
Time frame: Following 8-weeks of intervention
Ease of delivery by non-experts
Ease of delivery by non-experts, determined by comparing change in PHQ-9 by intervention lead (nurse vs psychologist)
Time frame: Following 8-weeks of intervention
Ease of delivery by non-expert
Ease of delivery by non-expert, as determined by comparing chnage in PDQ-39 by intervention lead (nurse vs psychologist)
Time frame: Following 8-weeks of intervention
Ease of delivery by non-expert
Ease of delivery by non-expert, as determined by comparing change in Brief-COPE by intervention lead (nurse vs psychologist)
Time frame: Following 8-weeks of intervention
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.